TIRVA ROBERT L. (Interim CFO) sold 1.3% of their position (4.49K shares) of DNA X, INC. on the open market
Open‑market sale worth $2.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/13/2022ACC: 0000899243-22-022227
-4.49K
Net shares
Net seller
$2.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.49K
Price / share
$0.57
Trade value
$2.58K
% of position
1.3%
6/10/2022
339.38K→334.88K
Total
Net shares
−4.49K
Net value
-$2.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2022 | S · Sale | −4.49K | $0.57 | $2.58K | 1.3% | 339.38K | 334.88K |
| Total | −4.49K | -$2.58K | ||||||
Derivative Transactions0
No derivative transactions reported